Send to

Choose Destination
Indian J Urol. 2015 Apr-Jun;31(2):102-5. doi: 10.4103/0970-1591.154300.

Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand?

Author information

Division of Urology and Kidney Transplantation, American University of Beirut, Beirut, Lebanon.
Division of Oncology, American University of Beirut, Beirut, Lebanon.


Nephron-sparing surgery (NSS) for renal cell carcinoma (RCC) offers comparable oncologic results, but a lower risk of chronic kidney disease, when compared with radical nephrectomy. However, there are limited data in the literature examining the safety of NSS in the setting of metastatic RCC. To evaluate the feasibility of NSS and impact on cancer-specific survival (CSS) in patients with metastatic disease, we performed a systematic review of the literature. There is ample evidence that NSS is feasible in metastatic RCC, with comparable results in terms of CSS compared with radical cytoreductive nephrectomy.


Metastatic; partial nephrectomy; renal cell carcinoma

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center